Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
The largest amount of evidence for bioresorbable vascular scaffold (BVS) use in clinical practice derives from Absorb trials and registries. Comparison of Absorb BVS with metallic stents resulted in increased rates of target lesion failure and device thrombosis in the Absorb BVS group. We investigat...
Enregistré dans:
Auteurs principaux: | Beytullah Cakal, Sinem Cakal, Oguz Karaca, Mehmet Omaygenc, Filiz Yilmaz, Haci Gunes, Ozgur Ozcan, Arzu Yıldırım, Bilal Boztosun |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Termedia Publishing House
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e3cd304ec9144aedbc315e1eb6589b5f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
par: Piotr Desperak, et autres
Publié: (2020) -
Bioresorbable vascular scaffolds technology: current use and future developments
par: Giacchi G, et autres
Publié: (2016) -
Long-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting
par: Jeremías Bayón, et autres
Publié: (2021) -
Long-term outcomes of Absorb bioresorbable vascular scaffold using predilation, sizing, and postdilation protocol in a real-world patient population
par: Sinem Çakal, et autres
Publié: (2021) -
Failed transcatheter mitral valve-in-ring implantation followed by transapical valve-in-valve within the ring and ad hoc paravalvular leak closure
par: Beytullah Çakal, et autres
Publié: (2021)